I appreciate the question. Certainly it is fundamental to ensure the TRQ allocations to those who have bricks and mortar within the country. There have been billions of dollars spent in investing in Canadian processing capacity and capabilities, and when you talk about the shot in the arm, what it's going to do is reaffirm that continued investment. Certainly the CETA allocation of TRQs was not a shot in the arm for Canadian dairy processors being able to invest in cheese manufacturing in Canada.
Looking at that investment or that TRQ that is allocated—and we're asking for north of 90%—the shot in the arm gives us the ability to understand the stability of the marketplace, to build on what Dave Wiens was talking about, because you have to have stability on the supply side, but you also have to have stability on the capacity side.
It's not surprising that we're both sitting here together, because there's no sense in producing if you have no processing. What we need as a shot in the arm is stability in return. Our members are seeing a 30% to 50% decline in sales and a 80% decline in EBITDA. That type of COVID impact is going to have a considerable impact.
It may not be the shot in the arm, in the sense of a punch in the shoulder, but maybe an adrenaline shot that allows us to see stability in the market.